Related Experiment Videos
[Antiphospholipid syndrome and multiple sclerosis: differential-diagnostic aspects]
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|November 7, 2002
Summary
Differentiating antiphospholipid syndrome (APS) from multiple sclerosis (MS) is challenging due to overlapping symptoms. This study identifies key clinical, immunological, and MRI criteria to distinguish between MS with anticardiolipin antibodies and APS.
Area of Science:
- Neurology
- Immunology
- Rheumatology
Context:
- Distinguishing between multiple sclerosis (MS) and antiphospholipid syndrome (APS) presents diagnostic challenges due to overlapping clinical and imaging features.
- Patients with definite MS and high anticardiolipin IgG antibodies (MS aCL(+)) were compared with patients diagnosed with APS.
Purpose:
- To identify differential diagnostic criteria for differentiating MS aCL(+) from APS.
- To investigate the clinical, immunological, and magnetic resonance imaging (MRI) peculiarities of MS aCL(+) and APS.
Summary:
- Some clinical and MRI findings in APS mimic MS, complicating diagnosis.
- MS aCL(+) exhibits unique features, including progressive myelitic patterns and atypical lesions (articular, cutaneous, vasospastic).
- APS can manifest with cerebrovascular disease, demyelinating polyneuropathy, and autoimmune myopathy.
Impact:
- Establishes distinct clinical, immunological, and MRI criteria for differentiating MS aCL(+) and APS.
- Highlights the diverse neurological and systemic manifestations of APS beyond cerebrovascular events.
- Aids clinicians in accurate diagnosis and management of patients presenting with overlapping neurological symptoms.